Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer

Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer

IntroductionNumerous studies have suggested high concordance between tissue and circulating tumor DNA (ctDNA) comprehensive genomic profiling (CGP) tests but only few of them focused on fusions. In addition, atypical breakpoints occasionally detected from DNA-based fusion detection make interpretati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Young-gon Kim, Boram Lee, Changhee Ha, Cheonghwa Lee, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Myung-Ju Ahn, Yoon-La Choi, Sehhoon Park, Jong-Won Kim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Series:	Frontiers in Oncology
Subjects:	circulating-tumor DNA ctDNA gene fusion non-small cell lung cancer comprehensive genomic profiling
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1463341/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Research trends and prospects of Circulating tumor DNA associated with colorectal cancer: a bibliometric analysis
by: Shusen Xia, et al.
Published: (2025-08-01)

Bibliometric analysis of global research trends and prospects on circulating tumor DNA in colorectal cancer
by: Jing Pang, et al.
Published: (2024-11-01)

Optimization of bile preparation for liquid biopsy in cholangiocarcinoma focusing on circulating tumor DNA and protein stability
by: Jin-Yi Han, et al.
Published: (2025-04-01)

Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives
by: Yi Wang, et al.
Published: (2025-07-01)

Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
by: Naing Lin Shan, et al.
Published: (2024-12-01)

Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
by: Andrew G. Hadd, et al.
Published: (2025-03-01)

Comparison of level of circulating tumor DNA between oral squamous cell carcinoma and healthy controls: a case control study
by: Samrina Mohammad, et al.
Published: (2025-07-01)

Longitudinal Tracking of ALK-Rearranged NSCLC From Plasma Using Circulating Tumor RNA and Circulating Tumor DNA
by: Simon Heeke, PhD, et al.
Published: (2025-04-01)

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside Implementations
by: Xuehan Yan, et al.
Published: (2025-06-01)

The importance of circulating tumor products as „liquid biopsies” in colorectal cancer
by: Alina Miscoci, et al.
Published: (2018-04-01)

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer
by: Maibritt Nørgaard, et al.
Published: (2025-04-01)

The role of circulating tumor DNA in melanomas of the uveal tract
by: Mohammed Zeeshan Zameer, et al.
Published: (2024-12-01)

International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
by: Nicola Fusco, et al.
Published: (2025-06-01)

The Application of Circulating Tumour DNA (ctDNA) in the Diagnosis, Prognosis, and Treatment Monitoring of Gynaecological and Breast Cancers (Review)
by: Aleksandra Englisz, et al.
Published: (2025-05-01)

Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker studyResearch in context
by: Lissa Wullaert, et al.
Published: (2025-09-01)

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients
by: Dong Lin, et al.
Published: (2025-07-01)

A perspective review on the systematic implementation of ctDNA in phase I clinical trial drug development
by: Nolwen Guigal-Stephan, et al.
Published: (2025-03-01)

Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents
by: Anne C. Chiang, MD, PhD, et al.
Published: (2025-09-01)

Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach
by: Andrew J. Pellatt, et al.
Published: (2025-07-01)

Exploring the Clinical Value of Perioperative ctDNA‐Based Detection of Molecular Residual Disease in Patients With Esophageal Squamous Cell Carcinoma
by: Jimin Li, et al.
Published: (2025-02-01)

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors
by: Kristian Egebjerg, et al.
Published: (2025-08-01)

Circulating tumor DNA laboratory processes and clinical applications in nasopharyngeal carcinoma
by: Ziman Wu, et al.
Published: (2025-05-01)

Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications
by: Youssef Elshimy, et al.
Published: (2025-05-01)

The advances of DNA methylation in the liquid biopsy for the detection of lung cancer
by: Yuxuan Chen, et al.
Published: (2025-07-01)

Methylated ARHGAP40 DNA as a potential biomarker for early diagnosis in high-grade ovarian serous cancer
by: Jiaxin Chai, et al.
Published: (2025-07-01)

The growing field of liquid biopsy and its Snowball effect on reshaping cancer management
by: Roberto Borea, et al.
Published: (2025-06-01)

The impact of liquid biopsy in breast cancer: Redefining the landscape of non-invasive precision oncology
by: Shaivy Malik, et al.
Published: (2025-06-01)

Circulating Tumor DNA in Primary and Secondary Liver Cancers: A Comprehensive Review
by: Hanna Hong, et al.
Published: (2025-06-01)

Circulating tumor DNA profiling for non-invasive genomic analysis in Indian lung cancer patients: A real-world experience
by: Prerana Jha, et al.
Published: (2025-06-01)

The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
by: Ruoyi Yang, et al.
Published: (2024-11-01)

Circulating tumor DNA monitoring in advanced mutated melanoma (LIQUID-MEL)
by: Martines Gianmarco, et al.
Published: (2025-06-01)

The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers
by: Ronan J. Kelly, et al.
Published: (2025-02-01)

Role of circulating tumor DNA and cell-free DNA biomarkers in diagnosis and prognosis of oral cancer - a systematic review
by: Samrina Mohammad, et al.
Published: (2025-04-01)

Exploring the potential of cell-free tumor DNA in bronchoscopic diagnosis of peripheral lung lesions—the DRILL study
by: Amanda Juul, et al.
Published: (2025-12-01)

Circulating tumor DNA (ctDNA) Detection via electrochemical Biosensing Tools
by: Sonya Sahin, et al.
Published: (2024-06-01)

Brief Report: Prospective Trial of Pembrolizumab Monotherapy in Metastatic NSCLC Evaluating Circulating Tumor DNA as a Surrogate Biomarker of Response
by: Iris van 't Erve, PhD, et al.
Published: (2025-09-01)

Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients
by: Aparna Ganesan, et al.
Published: (2025-07-01)

Editorial: Challenges and advances in carcinomatous meningitis treatment
by: Maciej M. Mrugala, et al.
Published: (2025-08-01)

Prognostic significance of circulating tumor DNA in urothelial carcinoma patients undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis
by: Qingping Ma, et al.
Published: (2025-04-01)

The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
by: David Sinclair Thomas Junior, et al.
Published: (2025-05-01)